• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • About
    • Contact
    • Privacy
    • Terms of use
  • Advertise
    • Advertising
    • Case studies
    • Design
    • Email marketing
    • Features list
    • Lead generation
    • Magazine
    • Press releases
    • Publishing
    • Sponsor an article
    • Webcasting
    • Webinars
    • White papers
    • Writing
  • Subscribe to Newsletter

Robotics & Automation News

Where Innovation Meets Imagination

  • Home
  • News
  • Features
  • Editorial Sections A-Z
    • Agriculture
    • Aircraft
    • Artificial Intelligence
    • Automation
    • Autonomous Vehicles
    • Business
    • Computing
    • Construction
    • Culture
    • Design
    • Drones
    • Economy
    • Energy
    • Engineering
    • Environment
    • Health
    • Humanoids
    • Industrial robots
    • Industry
    • Infrastructure
    • Investments
    • Logistics
    • Manufacturing
    • Marine
    • Material handling
    • Materials
    • Mining
    • Promoted
    • Research
    • Robotics
    • Science
    • Sensors
    • Service robots
    • Software
    • Space
    • Technology
    • Transportation
    • Warehouse robots
    • Wearables
  • Press releases
  • Events

Galen Robotics closes oversubscribed $15 Million Series A funding round

October 31, 2022 by Mark Allinson

Galen Robotics, which describes itself as a “digital-surgery-as-a-service pioneer”, has completed the first close for an oversubscribed Series A round with $15 million in funding, including investment from Ambix Healthcare Partners, from Menlo Park, California.

Galen Robotics has submitted a new collaborative soft tissue surgical robot, intended to address unmet needs in the market, to FDA for consideration.

Galen plans to level the surgical playing field by erasing large capital expenditures associated with today’s surgical robots. Galen Robotics will be the first surgical robotics company to launch as “as-a-service” using the per-usage disposable model.

Termed Digital-Surgery-as-a-Service, is a new approach to surgical robotics, clearing the way to capture surgical data and promote continuous improvements of surgical techniques, outcomes, and the training of residents.

The Series A helped complete the final robot prototype, and submission to FDA. Funds will also be used to develop a clinical sales team, expand engineering, grow product development, and develop surgeon training programs.

Galen was founded in 2016 to commercialize the research originating from Johns Hopkins University.

Once cleared, the Galen robot is intended for minimally invasive procedures and is envisioned to aid surgeons with very little disturbance to current surgical workflows.

Galen’s initial indications will focus on laryngological procedures. Future clearances will expand the scope of the platform into ENT, neurosurgery, spine, and cardiothoracic procedures.

Bruce Lichorowic, president and CEO, Galen Robotics, says: “Because the pandemic wreaked havoc on hospital profits with elective surgeries being postponed, we had to pivot our business model from hospitals paying up front for capital equipment to ‘as a service’.

“We will be the first robotic company to launch using an on-demand business model.”

Dr Arron Berez, managing director, Ambix Healthcare Partners, says: “It was an easy and quick decision for our firm to lead the Galen Series A funding round.

”We watched this team take an early surgical robotic prototype from Johns Hopkins University’s Robotics Lab, develop it into a potential game changer, and submit it to FDA, all during a pandemic.

“Add to that the current state of supply chain issues, and economic uncertainty, and we’re very impressed with how this team was able to consistently execute and hit their milestones.”

To accommodate anticipated demand for this new technology, and manage the Covid-affected supply-chain, the company opened a second close for the Series A funding round for an additional $5 million. The second close is expected to go quickly given the company’s stage and forward progress.

Print Friendly, PDF & Email

Share this:

  • Click to print (Opens in new window) Print
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on X (Opens in new window) X
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Telegram (Opens in new window) Telegram
  • Click to share on Pocket (Opens in new window) Pocket

Related stories you might also like…

Filed Under: Health, News Tagged With: close, company, develop, fda, funding, galen, model, procedures, robot, robotics, round, series, surgical, team

Primary Sidebar

Search this website

Latest articles

  • Mitsubishi Electric says its robots are ‘bridging skills gaps’ in automation technology
  • Pusan National University scientists develop ‘game-changing method’ to create safer, long-lasting lithium-ion batteries
  • Fraunhofer develops ‘resource-efficient’ measurement system for semiconductor wafer production
  • Tokyo University scientists discover key to ‘stable, high-performance, and long-life’ sodium-ion batteries
  • Swiss Steel develops ‘sustainable and easy-to-machine special steels’ for automotive industry
  • How to Calculate Diminished Value for Your Car After an Accident
  • Gartner predicts one in 20 supply chain managers will manage robots, not humans, by 2030
  • Moldova launches new incubator for robotics, digital agriculture, and foodtech
  • Pudu Robotics launches new industrial sweeper and vacuum
  • Out of thin air: MIT engineers develop device that creates safe drinking water from air

Secondary Sidebar

Copyright © 2025 · News Pro on Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT